BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Arthritis, Lung, Personalized medicine, Doxorubicin, rs7903146, GATA1, Angiogenesis)
Bookmark Forward

QuickView for Beclin1;jsessionid=24E67D34A3F2B87830CA5D9D30CA10B1;jsessionid=E82997F21DEBC8FE83CCDFB1618B2407;jsessionid=98BBE09D5D2EB66B6EB82BB4211A7CBE;jsessionid=1E4EB686773C4C814DEDF6910F2E2888;jsessionid=E86B04F3CA6027AB9EDBACCE013C5C46 (gene)


Body Atlas

Most Correlated Tissues

  1. Eosinophil of peripheral blood
  2. Colon mucosa
  3. Basophil of peripheral blood
  4. Microglial cell
  5. Monocyte of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Disorder of intraocular pressure
  2. Pyloric ulcer
  3. Multiple-resistant Staphylococcus aureus infection
  4. Disease due to Arenavirus
  5. Perforation of tympanic membrane
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. mycophenolate mofetil
  2. Minocycline
  3. Todralazine
  4. fipexide
  5. IGF2 protein, human
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. CDHR2
  2. SALL3
  3. PTGES
  4. CSH2
  5. PCDH11X
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

There were no matches for Beclin1;jsessionid=24E67D34A3F2B87830CA5D9D30CA10B1;jsessionid=E82997F21DEBC8FE83CCDFB1618B2407;jsessionid=98BBE09D5D2EB66B6EB82BB4211A7CBE;jsessionid=1E4EB686773C4C814DEDF6910F2E2888;jsessionid=E86B04F3CA6027AB9EDBACCE013C5C46
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for Beclin1;jsessionid=24E67D34A3F2B87830CA5D9D30CA10B1;jsessionid=E82997F21DEBC8FE83CCDFB1618B2407;jsessionid=98BBE09D5D2EB66B6EB82BB4211A7CBE;jsessionid=1E4EB686773C4C814DEDF6910F2E2888;jsessionid=E86B04F3CA6027AB9EDBACCE013C5C46
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.